Log in or Sign up for Free to view tailored content for your specialty!
Autism Spectrum Disorders News
Study sees link between lithium in water and autism that ‘requires further scrutiny’
A study of more than 50,000 children born over a 14-year period in Denmark found that children born to mothers who were exposed to higher levels of lithium in their drinking water were moderately more likely to develop autism.
Targeted cognitive training improves working memory, information processing in autism
Targeted cognitive training increased auditory memory, processing speed and perception among adolescents and young adults with autism spectrum disorder, according to data published in the Journal of Clinical Medicine.
Log in or Sign up for Free to view tailored content for your specialty!
Maternal primary immunodeficiency linked to offspring’s psychiatric disorders, suicidality
Children born to mothers, not fathers, with primary antibody immunodeficiencies had greater risks for certain psychiatric disorders and for suicidal behavior, according to data published in JAMA Psychiatry.
Canadian biotech firm granted exemption to initiate phase 2 psilocybin study
Nova Mentis Life Science Corp. has received an exemption under Section 56 of the Health Canada Controlled Drugs and Substances Act to advance a phase 2a clinical trial examining oral microdose psilocybin therapy for fragile X syndrome.
Zelira Therapeutics receives funding for FDA trials of cannabinoid drug for ASD
Biopharmaceutical company Zelira Therapeutics has received $8.6 million in funding for the study of its cannabinoid drug for use in patients with autism spectrum disorder, according to a company press release.
Autism rates jump, especially among children without co-occurring intellectual disability
The estimated prevalence of autism among 8-year-olds in a New Jersey study more than tripled during a 6-year period, including a fivefold increase in children with autism who do not have a co-occurring intellectual disability.
LinusBio raises $16M for novel platform to aid diagnosis, treatment of ALS, autism
LinusBio announced it has raised over $16 million in Series A funding to deliver technology that combines genomics, the environment and biological response to help diagnose and monitor the progression of disorders such as ALS and autism.
Antipsychotic prescriptions for children increased by 3.3% annually over 2 decades
The prevalence of all antipsychotic prescriptions prescribed to those aged 3 to 18 years increased by an average of 3.3% annually from 2000 to 2019, researchers reported in The Lancet Psychiatry.
KGK Sciences receives approval for psilocybin clinical trial in Canada
KGK Sciences Inc. received a no objection letter from Health Canada to proceed with a phase 2a clinical trial evaluating the use of psilocybin for fragile X syndrome, the leading genetic cause of autism spectrum disorder.
Deep learning may help predict mental disorder diagnosis
A multidiagnostic prediction model developed using deep learning was highly predictive of mental disorder diagnosis, according to new data published in JAMA Psychiatry.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read